The conformational IgE epitope profile of soya bean allergen Gly m 4

Summary Background Birch pollen‐related soya allergy is mediated by Gly m 4. Conformational IgE epitopes of Gly m 4 are unknown. Objective To identify the IgE epitope profile of Gly m 4 in subjects with birch pollen‐related soya allergy utilizing an epitope library presented by Gly m 4‐type model pr...

Full description

Saved in:
Bibliographic Details
Published inClinical and experimental allergy Vol. 46; no. 11; pp. 1484 - 1497
Main Authors Husslik, F., Nürnberg, J., Seutter von Loetzen, C., Mews, T., Ballmer-Weber, B. K., Kleine-Tebbe, J., Treudler, R., Simon, J.-C., Randow, S., Völker, E., Reuter, A., Rösch, P., Vieths, S., Holzhauser, T., Schiller, D.
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.11.2016
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Summary Background Birch pollen‐related soya allergy is mediated by Gly m 4. Conformational IgE epitopes of Gly m 4 are unknown. Objective To identify the IgE epitope profile of Gly m 4 in subjects with birch pollen‐related soya allergy utilizing an epitope library presented by Gly m 4‐type model proteins. Methods Sera from patients with (n = 26) and without (n = 19) allergy to soya as determined by oral provocation tests were studied. Specific IgE (Bet v 1/Gly m 4) was determined by ImmunoCAP. A library of 59 non‐allergenic Gly m 4‐type model proteins harbouring individual and multiple putative epitopes for IgE was tested in IgE binding assays. Primary, secondary and tertiary protein structures were assessed by mass spectrometry, circular dichroism and nuclear magnetic resonance spectroscopy. Results All subjects were sensitized to Gly m 4 and Bet v 1. Allergen‐specific serum IgE levels ranged from 0.94 to > 100 kUA/L. The avidities of serum IgE were 5.06 ng (allergic) and 1.8 ng (tolerant) as determined by EC50 for IgE binding to Gly m 4. 96% (46/48) of the protein variants bound IgE. Model proteins had Gly m 4‐type conformation and individual IgE binding clustered in six major surface areas. Gly m 4‐specific IgE binding could be inhibited to up to 80% by model proteins harbouring individual IgE binding sites in an epitope‐wise equimolar fashion. Receiver operating curve analysis revealed an area under fitted curve of up to 0.88 for model proteins and 0.66 for Gly m 4. Conclusion and Clinical Relevance Serum levels and avidity of Gly m 4‐specific IgE do not correlate with clinical reactivity to soya. Six IgE‐binding areas, represented by 23 amino acids, account for more than 80% of total IgE binding capacity of Gly m 4. Model proteins may be used for epitope‐resolved diagnosis to differentiate birch‐soya allergy from clinical tolerance.
Bibliography:ark:/67375/WNG-C5QCX604-1
ArticleID:CEA12796
German Federal Ministry of Education and Research - No. FK 01KG0911
istex:52E318043A963D20E5DD42BA83DC473B119499D7
Figure S1. Mass spectrometric sequence confirmation of recombinant ∆51NCS, ∆29NCS and Gly m 4 variants. Figure S2. CD and R(H) of Gly m 4 and Gly m 4N42I/E44S/N46D/K54A. Figure S3. Amino acids of Gly m 4 selected for mutational epitope analysis. Figure S4. Recombinant Δ51NCS variants. Table S1. Parameter of mass spectrometric sequence confirmation. Table S2. Candidate amino acids of Gly m 4 and their corresponding counterparts of Δ51NCS. Table S3. Human sera used in this study. Table S4. IgE binding of Gly m 4-type NCS variants.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0954-7894
1365-2222
DOI:10.1111/cea.12796